December 28, 2023
Shionogi said on December 27 that Ildong Pharmaceutical, a partner in South Korea, has filed for a manufacturing license for the oral COVID-19 treatment Xocova (ensitrelvir) in the country, seeking to switch to the drug’s local production and supply. In...read more